Net profit of ERIS Lifesciences rose 32.11% to Rs 93.84 crore in the quarter ended March 2025 as against Rs 71.03 crore during the previous quarter ended March 2024. Sales rose 28.38% to Rs 702.60 crore in the quarter ended March 2025 as against Rs 547.27 crore during the previous quarter ended March 2024.

For the full year,net profit declined 10.26% to Rs 351.84 crore in the year ended March 2025 as against Rs 392.05 crore during the previous year ended March 2024. Sales rose 44.59% to Rs 2879.26 crore in the year ended March 2025 as against Rs 1991.30 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	702.60	547.27	28	2879.26	1991.30	45
OPM %	35.92	27.12	-	35.33	33.89	-
PBDT	206.12	130.55	58	804.33	613.85	31
PBT	128.87	76.75	68	488.87	431.34	13
NP	93.84	71.03	32	351.84	392.05	-10

Powered by Capital Market - Live News